Status:
COMPLETED
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
Lead Sponsor:
Cepheid
Collaborating Sponsors:
Emory University
Conditions:
HCV
Eligibility:
All Genders
18+ years
Brief Summary
A multi-site prospective, all comers study that was conducted at geographically diverse locations in the United States.
Detailed Description
Whole blood specimens were collected from consented individuals with signs and symptoms and/or individuals at-risk of HCV infection, irrespective of HCV antibody status at a single timepoint.
Eligibility Criteria
Inclusion
- Participant was ≥18 years old
- Participant was not on treatment at time of enrollment based on review of medical records or self-reported
- Participant had signs and symptoms and/or is considered at-risk of HCV infection
Exclusion
- Clinician assessed that the participant was not suitable for inclusion
Key Trial Info
Start Date :
February 6 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2024
Estimated Enrollment :
1012 Patients enrolled
Trial Details
Trial ID
NCT06508996
Start Date
February 6 2024
End Date
June 6 2024
Last Update
July 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40508